Unaudited Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Revision of Prior Period, Adjustment	Impact of ASC 326 adoption	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Revision of Prior Period, Adjustment	Non controlling Interests	Non controlling Interests Revision of Prior Period, Adjustment	Accumulated Deficit	Accumulated Deficit Impact of ASC 326 adoption	Treasury Stock
Beginning balance at Dec. 31, 2021	$ 0
Ending balance at Mar. 31, 2022	0
Balance (in shares) at Dec. 31, 2021				140,540,671
Balance at Dec. 31, 2021	361,810			$ 14	$ 461,207		$ 0		$ (99,411)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				1,312,320
Exercise of stock options	258				258
Issuance of restricted stock (in shares)				2,205
Stock-based compensation expense	381				381
Net income (loss)	$ (16,077)								(16,077)
Issuance of shares as contingent consideration relating to Quantum business acquisition (in shares)	100,000
Issuance of shares as contingent consideration relating to Quantum business acquisition	$ 186				186
Balance (in shares) at Mar. 31, 2022				141,955,196
Balance at Mar. 31, 2022	346,558			$ 14	462,032		0		(115,488)
Ending balance at Jun. 30, 2022	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				440,065
Exercise of stock options	175				175
Issuance of restricted stock (in shares)				97,572
Stock-based compensation expense	1,081				1,081
Net income (loss)	(12,698)								(12,698)
Balance (in shares) at Jun. 30, 2022				142,492,833
Balance at Jun. 30, 2022	335,116			$ 14	463,288		0		(128,186)
Beginning balance at Dec. 31, 2022	85
Increase (Decrease) in Temporary Equity [Roll Forward]
Fair value adjustment for Spruce Acquisition	240
Capital distributions to noncontrolling interests	(108)
Net income	(39)
Ending balance at Mar. 31, 2023	178
Balance (in shares) at Dec. 31, 2022				144,375,226
Balance at Dec. 31, 2022	288,891		$ 1,285	$ 14	473,277		8,942		(193,342)	$ 1,285	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Fair value adjustment for Spruce Acquisition		$ (7,303)				$ (1,813)		$ (5,490)
Exercise of stock options (in shares)				1,081,679
Exercise of stock options	283				283
Issuance of restricted stock (in shares)				2,731,919
Issuance of common stock (in shares)				206,546
Issuance of common stock	150				150
Capital distributions to noncontrolling interests	(88)						(88)
Stock-based compensation expense	796				796
Net income (loss)	(18,805)						590		(19,395)
Balance (in shares) at Mar. 31, 2023				148,395,370
Balance at Mar. 31, 2023	265,209			$ 14	472,693		3,954		(211,452)		0
Beginning balance at Dec. 31, 2022	85
Ending balance at Jun. 30, 2023	199
Balance (in shares) at Dec. 31, 2022				144,375,226
Balance at Dec. 31, 2022	288,891		$ 1,285	$ 14	473,277		8,942		(193,342)	$ 1,285	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share repurchases	(1,600)
Balance (in shares) at Jun. 30, 2023				150,143,890
Balance at Jun. 30, 2023	265,966			$ 14	473,538		2,415		(208,387)		(1,614)
Beginning balance at Mar. 31, 2023	178
Increase (Decrease) in Temporary Equity [Roll Forward]
Net income	21
Ending balance at Jun. 30, 2023	199
Balance (in shares) at Mar. 31, 2023				148,395,370
Balance at Mar. 31, 2023	265,209			$ 14	472,693		3,954		(211,452)		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				893,093
Exercise of stock options	252				252
Issuance of restricted stock (in shares)				855,427
Capital distributions to noncontrolling interests	(57)						(57)
Share repurchases	(1,614)										(1,614)
Stock-based compensation expense	593				593
Net income (loss)	1,583						(1,482)		3,065
Balance (in shares) at Jun. 30, 2023				150,143,890
Balance at Jun. 30, 2023	$ 265,966			$ 14	$ 473,538		$ 2,415		$ (208,387)		$ (1,614)